Inzidenz der Herzinsuffizienz rückläufig?

Abstract

Evaluation of the heart failure (HF) incidence in Olmsted County (Minnesota/USA) revealed a decline from 316 per 100,000 in 2000 to 219 per 100,000 in 2010 equating to a relative reduction of 37.5 %. The decline in HF incidence was greater for HFrEF than for HFpEF (– 45 % vs. – 28 %) und smaller in men than in women (-29 % vs. – 43 %). Notebly, it was independent from age. The 1-year mortality rate was 20.2 %. Noncardiovascular causes were the predominent reasons for both mortality and hospitalizations. Neither mortality nor hospitalization rate declined over time. Sound data on the HF incidence are currently not available for Germany. However, the total number of HF-related hospitalizations increased during the period from 2000 to 2014. This phenomenon is most likely due to an increased prevalence secondary to optimized HF therapy and changes in demography with a higher HF hospitalization rate in elderly patients.

• Literatur

• 1 Haass M. Leitliniengerechte medikamentöse Therapie der Herzinsuffizienz. Aktuel Kardiol 2014; 3: 1-7
• 2 McMurray JJ, Adamopoulos S, Anker SD et al. ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 2012; 33: 1787-1847
• 3 Barker WH, Mullooly JP, Getchell W. Changing incidence and survival for heart failure in a well-defined older population, 1970-1974 and 1990-1994. Circulation 2006; 113: 799-805
• 4 Roger VL, Weston SA, Redfield MM et al. Trends in heart failure incidence and survival in a community-based population. JAMA 2004; 292: 344-350
• 5 Curtis LH, Whellan DJ, Hammill BG et al. Incidence and prevalence of heart failure in elderly persons, 1994–2003. Arch Intern Med 2008; 168: 418-424
• 6 Gerber Y, Weston SA, Redfield MM et al. A contemporary appraisal of the heart failure epidemic in Olmsted County, Minnesota, 2000 to 2010. JAMA 2015; 175: 996-1004
• 7 McKee PA, Castelli WP, McNamara PM et al. Natural history of congestive heart failure: the Framingham Study. N Engl J Med 1971; 285: 1441-1446
• 8 Yeh RW, Sidney S, Chandra M et al. Population trends in the incidence and outcomes of acute myocardial infarction. N Engl J Med 2010; 362: 2155-2165
• 9 Gerber Y, Weston SA, Berardi C et al. Contemporary trends in heart failure with preserved and reduced ejection fraction after myocardial infarction: a community study. Am J Epidemiol 2013; 178: 1272-1280
• 10 Oremus M, McKelvie R, Don-Wauchope A et al. A systematic review of BNP and NTproBNP in the management of heart failure: overview and methods. Heart Fail Rev 2014; 19: 413-419
• 11 Bleuminik GS, Knetsch AM, Sturkenboom MC et al. Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure. The Rotterdam Study. Eur Heart J 2004; 25: 1614-1619
• 12 Barasa A, Schaufelberg M, Lappas G et al. Long-term trends in young adults: 20-year trends in hospitalization, aetiology, and case fatality in Sweden. Eur Heart J 2014; 35: 25-32
• 13 Zile MR, Gaasch WH, Anand IS et al. Mode of death in patients with heart failure and preserved ejection fraction: results from the Irbesartan in Heart Failure with Preserved Ejection Fraction (I-PRESERVE) trial. Circulation 2010; 121: 1343-1405
• 14 Gesundheitsberichterstattung des Bundes. Im Internet: http://www.gbe-bund.de/stichworte/HERZINSUFFIZIENZ.html (Stand: 26. 1. 2016)